Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 '22

Dallas, Texas--(Newsfile Corp. - December 19, 2022) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners updates coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH). The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q322.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Strong IP Position
• Ongoing Clinical Trials
• First Patients Recently Dosed

Click image above to view full announcement.

About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
[email protected]

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/148698

You May Also Be Interested In

• City of Carson Secures $370 Million Tesoro/Marathon Settlement, Strengthening City Finances Without a Tax Increase
• Introducing the New Cobalt® Model R26 Luxury Sport Runabout, A Next-Generation Family-Size Day Boat
• BioMedNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Acquires Zoolzy to Expand Pharmaceutical Supply Chain and Veterinary Market Reach